Watchlist
Loading...
US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist
0.770 +0.040+5.48% Trading 11/29 14:46 ET
0.794High0.688Low164.36KVolume
Intraday
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About ADC Therapeutics Company

ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Revenue Breakdown

Business Unit:USD
2022/12/31
Stock NameRevenueRatio
Single segment209.91M100.00%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >